Drug Type Small molecule drug |
Synonyms SK-1501, Metoana, メトアナ + [1] |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors), PRKAB1 activators(Protein kinase AMP-activated non-catalytic subunit beta 1 activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (08 Jan 2016), |
Regulation- |
Molecular FormulaC19H25N7O2 |
InChIKeyLDXYBEHACFJIEL-HNNXBMFYSA-N |
CAS Registry739366-20-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | KR | 08 Jan 2016 |